Miranda Kirby Selected Research

Helium-3

8/2013	On the role of abnormal DL(CO) in ex-smokers without airflow limitation: symptoms, exercise capacity and hyperpolarised helium-3 MRI.
5/2013	Hyperpolarized helium-3 magnetic resonance imaging of chronic obstructive pulmonary disease exacerbation.
3/2013	Pulmonary ventilation visualized using hyperpolarized helium-3 and xenon-129 magnetic resonance imaging: differences in COPD and relationship to emphysema.
2/2012	Evaluating bronchodilator effects in chronic obstructive pulmonary disease using diffusion-weighted hyperpolarized helium-3 magnetic resonance imaging.
8/2011	Quantitative evaluation of hyperpolarized helium-3 magnetic resonance imaging of lung function variability in cystic fibrosis.
7/2011	Hyperpolarized ³He magnetic resonance imaging: preliminary evaluation of phenotyping potential in chronic obstructive pulmonary disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Miranda Kirby Research Topics

Disease

35	Chronic Obstructive Pulmonary Disease (COPD) 11/2022 - 07/2010
9	Emphysema 12/2021 - 01/2012
6	Asthma (Bronchial Asthma) 01/2020 - 09/2013
4	Dyspnea (Shortness of Breath) 11/2022 - 08/2014
4	Lung Diseases (Lung Disease) 04/2018 - 09/2013
2	COVID-19 11/2022 - 01/2022
2	Obstructive Lung Diseases (Obstructive Lung Disease) 10/2020 - 08/2014
2	Pulmonary Emphysema 01/2018 - 08/2013
2	Disease Progression 10/2016 - 09/2014
2	Cystic Fibrosis (Mucoviscidosis) 09/2013 - 08/2011
1	Infections 11/2022
1	Post-Acute COVID-19 Syndrome 11/2022
1	Lung Injury 12/2016
1	Airway Remodeling 04/2016
1	Respiratory Tract Diseases (Respiratory Tract Disease) 09/2013

Drug/Important Bio-Agent (IBA)

11	GoldIBA 01/2022 - 08/2013
9	Carbon MonoxideIBA 11/2022 - 11/2012
8	Biomarkers (Surrogate Marker)IBA 04/2018 - 08/2013
6	Helium-3IBA 08/2013 - 07/2011
5	Bronchodilator Agents (Bronchodilators)IBA 11/2022 - 10/2011
5	HeliumIBA 01/2020 - 07/2010
3	XenonIBA 11/2022 - 11/2012
2	SmokeIBA 01/2020 - 04/2016
2	Phenobarbital (Luminal)FDA Link 01/2020 - 01/2018
2	prednylidene (Pred)IBA 05/2017 - 01/2016
2	Albuterol (Salbutamol)FDA LinkGeneric 08/2014 - 10/2011
2	HydrogenIBA 10/2011 - 07/2010
1	A-factor (Streptomyces)IBA 10/2021
1	DNA (Deoxyribonucleic Acid)IBA 10/2020
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2020
1	funiferine N-oxideIBA 01/2018
1	Gonadal Steroid Hormones (Sex Hormones)IBA 04/2016
1	Clostridium perfringens epsilon-toxinIBA 08/2014
1	Tobacco Smoke Pollution (Passive Smoking)IBA 08/2014
1	Methacholine Chloride (Methacholine)FDA Link 01/2014
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2014
1	Xenon-129IBA 03/2013

Therapy/Procedure

5	Therapeutics 05/2017 - 10/2011
2	Lung Transplantation 01/2020 - 01/2018
1	Pneumonectomy (Lung Volume Reduction) 01/2018
1	Mechanical Ventilators (Ventilator) 12/2016
1	Bronchial Thermoplasty 09/2015
1	Stents 01/2012